# To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers

> **NCT03415243** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** Acetaminophen 650mg+Dextromethorphan 20mg+Phenylephrine 10mg
- **DRUG:** Acetaminophen 325mg+Dextromethorphan 10mg+Phenylephrine 5mg

## Key facts

- **NCT ID:** NCT03415243
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2018-03-29
- **Final completion:** 2018-03-29
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03415243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03415243, "To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03415243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*